| 产品名称: | Cryptococcus neoformans (Sanfelice) Vuillemin |
|---|---|
| 商品货号: | TS161416 |
| Deposited As: | Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph |
| Strain Designations: | N-2 |
| Alternate State: | Filobasidiella neoformans Kwon-Chung |
| Application: | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Type Strain: | no |
| Preceptrol®: | no |
| Medium: | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions: | Temperature: 24.0°C |
| Name of Depositor: | T Kobayashi |
| Chain of Custody: | ATCC < |
| Isolation: | human, Japan |
| References: | Kobayashi T, et al. Endotoxic substance of Cryptococcus neoformans. Mycopathol. Mycol. Appl. 54: 391-404, 1974. PubMed: 4215972 Kobayashi T. Experimental cryptococcosis in mice. 1. Influence of body weight, sex and strain of mice on infection with Cryptococcus neoformans. Jpn. J. Med. Mycol. 15: 52-57, 1974. |